Next Article in Journal
Metabolomic Investigations on Nesterenkonia flava Revealed Significant Differences between Marine and Terrestrial Actinomycetes
Next Article in Special Issue
Optimization of Growth and Carotenoid Production by Haloferax mediterranei Using Response Surface Methodology
Previous Article in Journal
Role of Mitochondria in Regulating Lutein and Chlorophyll Biosynthesis in Chlorella pyrenoidosa under Heterotrophic Conditions
Previous Article in Special Issue
Toward the Synthesis and Improved Biopotential of an N-methylated Analog of a Proline-Rich Cyclic Tetrapeptide from Marine Bacteria
Article Menu

Export Article

Open AccessReview
Mar. Drugs 2018, 16(10), 355; https://doi.org/10.3390/md16100355

Antibiotics from Deep-Sea Microorganisms: Current Discoveries and Perspectives

1
Institute of Protein Biochemistry, National Research Council, I-80131 Naples, Italy
2
Laboratoire d’Ingénierie des Systèmes Biologiques et des Procédés, INSA, 31400 Toulouse, France
3
Stazione Zoologica “Anthon Dorn”, Villa Comunale, I-80121 Naples, Italy
4
Department of Biology, University of Florence, Sesto Fiorentino, I-50019 Florence, Italy
5
Marine Biodiscovery Centre, Department of Chemistry, University of Aberdeen, Aberdeen, Scotland AB24 3UE, UK
These authors equally contributed to the work.
*
Author to whom correspondence should be addressed.
Received: 23 July 2018 / Revised: 25 September 2018 / Accepted: 27 September 2018 / Published: 29 September 2018
(This article belongs to the Special Issue Marine Bacteria as Sources of Bioactive Compounds)
Full-Text   |   PDF [1082 KB, uploaded 29 September 2018]   |  

Abstract

The increasing emergence of new forms of multidrug resistance among human pathogenic bacteria, coupled with the consequent increase of infectious diseases, urgently requires the discovery and development of novel antimicrobial drugs with new modes of action. Most of the antibiotics currently available on the market were obtained from terrestrial organisms or derived semisynthetically from fermentation products. The isolation of microorganisms from previously unexplored habitats may lead to the discovery of lead structures with antibiotic activity. The deep-sea environment is a unique habitat, and deep-sea microorganisms, because of their adaptation to this extreme environment, have the potential to produce novel secondary metabolites with potent biological activities. This review covers novel antibiotics isolated from deep-sea microorganisms. The chemical classes of the compounds, their bioactivities, and the sources of organisms are outlined. Furthermore, the authors report recent advances in techniques and strategies for the exploitation of deep-sea microorganisms. View Full-Text
Keywords: antibiotics; deep-sea; marine microorganisms; extreme habitat; marine sediments antibiotics; deep-sea; marine microorganisms; extreme habitat; marine sediments
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Tortorella, E.; Tedesco, P.; Palma Esposito, F.; January, G.G.; Fani, R.; Jaspars, M.; de Pascale, D. Antibiotics from Deep-Sea Microorganisms: Current Discoveries and Perspectives. Mar. Drugs 2018, 16, 355.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Mar. Drugs EISSN 1660-3397 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top